Walleye Capital LLC Intellia Therapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $439,756 - $610,128	22,300 Added 99.11%	44,800 $920,000
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $130,130 - $176,930	6,500 Added 40.63%	22,500 $503,000
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $304,896 - $419,839	-12,800 Reduced 44.44%	16,000 $440,000
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $490,992 - $685,608	21,200 Added 278.95%	28,800 $878,000
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $199,206 - $288,414	-6,300 Reduced 45.32%	7,600 $240,000
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $466,830 - $621,405	-13,500 Reduced 49.27%	13,900 $566,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $642,690 - $865,026	-19,300 Reduced 41.33%	27,400 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $1.26 Million - $2.38 Million	38,000 Added 436.78%	46,700 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $469,104 - $623,790	8,700 New	8,700 $487,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $1,114 - $2,287	-100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $67,968 - $112,176	-7,200 Reduced 98.63%	100 $1,000
Q4 2019 Feb 14, 2020	SELL	$10.43 - $17.67 $31,290 - $53,010	-3,000 Reduced 29.13%	7,300 $107,000
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $2,614 - $3,702	-200 Reduced 1.9%	10,300 $138,000
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $270,660 - $358,995	-19,500 Reduced 65.0%	10,500 $172,000
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $383,700 - $528,600	30,000 New	30,000 $512,000

315

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.19B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.